neurontin monograph canada gi side effects gabapentin

Patients who require concurrent treatment with opioids or other CNS depressants should be observed carefully for signs and symptoms of CNS depression, and the dose of gabapentin or opioid should be reduced accordingly. NEURONTIN® (gabapentin) Product Monograph Page 4 of 29 NEURONTIN (gabapentin) belongs to the family of medicines called antiepileptic drugs and is used for treating epilepsy (seizures). What it does: NEURONTIN has been prescribed for you by your doctor to reduce your number of seizures. When it should not be used: Do not use NEURONTIN if you are allergic to it or any of the NEURONTIN (gabapentin) is indicated as adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled by conventional therapy. 1.1 Pediatrics Pediatrics (< 18 years of age): Based on the data submitted and reviewed by Health Canada, the The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections: Part I: Health Professional Information; Part II: Scientific Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: ( the website or by calling 1 844-596-9526. Neurontin was evaluated for the management of postherpetic neuralgia (PHN) in 2 randomized, double-blind, placebo-controlled, multicenter studies; N=563 patients in the intent-to-treat (ITT) PRODUCT MONOGRAPH . Pr NEURONTIN®. Gabapentin . Capsules 100 mg, 300 mg, and 400 mg . Tablets 600 mg and 800 mg . Antiepileptic Agent . Pfizer Canada Inc. 17, 300 Trans-Canada Highway NEURONTIN (gabapentine) appartient à la famille de médicaments appelée antiépileptiques. Il sert à traiter l'épilepsie (les convulsions). NEURONTIN vous a été prescrit par votre médecin pour réduire le nombre de crises que vous avez. ci-dessous). GABAPENTIN Product Monograph Page 3 of 32 PrGABAPENTIN Gabapentin Capsules, House Standard 100 mg, 300 mg and 400 mg PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength All Non-medicinal Ingredients Oral Capsules: 100 mg, 300 mg, and 400 mg Corn Starch, Lactose Anhydrous, and Talc. Tell your doctor immediately if you experience increased side effects such as drowsiness or slowed breathing while taking GABAPENTIN with an opioid or other sedatives and tranquilizers. The dose of these drugs or GABAPENTIN may need to be adjusted. Avoid alcoholic drinks while taking GABAPENTIN. The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections: Part I: Health Professional Information; Part II: Scientific PRODUCT MONOGRAPH PrNEURONTIN® Gabapentin Capsules 100 mg, 300 mg, and 400 mg Tablets 600 mg and 800 mg Antiepileptic Agent May 5, 2020 Date of Revision: ©Upjohn Canada ULC,2020 Upjohn Canada ULC, Licensee ®Warner-Lambert CompanyLLC Submission Control No.: 237475 H9J 2M5 Kirkland, Quebec 17300Trans-Canada Highway UpjohnCanadaULC women. Gabapentin should only be used during pregnancy if the potential benefit to the mother outweighs the potential risk to the fetus. Nursing Women: Gabapentin is excreted in human milk. Because the effect on the nursing infant is unknown, caution should be exercised when gabapentin is administered to a nursing mother. PrNEURONTINMD (gabapentine) Capsules dosées à 100, à 300 et à 400 mg Comprimés dosés à 600 et à 800 mg Antiépileptique Upjohn Canada SRI 17300, autoroute Transcanadienne Kirkland, Québec H9J 2M5 Date de révision : 05 mai 2020 Numéro de contrôle : 237475 M.D. de Warner-Lambert Company LLC Upjohn Canada SRI, licencié GABAPENTIN (gabapentin) Page 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrGABAPENTIN Gabapentin Capsules Capsules, 100 mg, 300 mg, and 400 mg, Oral Teva Standard Antiepileptic Agent Teva Canada Limited 30 Novopharm Court, Toronto, Ontario PRODUCT MONOGRAPH PrTEVA-GABAPENTIN Gabapentin Capsules 100 mg, 300 mg, and 400 mg Tablets 600 mg and 800 mg Antiepileptic Agent Teva Standard Teva Canada Limited 30 Novopharm Court, Toronto, Ontario Date of Revision: December 6, 2017 Canada M1B 2K9 www.tevacanada.com Submission Control No: 211039 Footnotes Footnote 1. The earliest marketed date recorded in the Drug Product Database. Return to footnote 1 referrer. Footnote 3. The American Hospital Formulary Service permits an easy review of information on a group of drugs with similar activities and uses and allows the reader to determine quickly the similarities and differences among drugs within a group. Neurontin (gabapentin) is indicated as adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled by conventional therapy. Systematic studies in geriatric patients have not been conducted. (See WARNINGS AND PRECAUTIONS, Special Populations). PRODUCT MONOGRAPH Pr Gabapentin Gabapentin Tablets, House Standard 600 mg and 800 mg Antiepileptic Agent JAMP Pharma Corporation 1310 rue Nobel Boucherville, Quebec TEVA-GABAPENTIN (gabapentin) is indicated as adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled by conventional therapy.

neurontin monograph canada gi side effects gabapentin
Rating 5 stars - 1371 reviews




Blog

Articles and news, personal stories, interviews with experts.

Video